{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:46:53Z","timestamp":1787244413735,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12325-025-03428-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:37:40Z","timestamp":1768203460000},"page":"1129-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-2897","authenticated-orcid":false,"given":"Richard B.","family":"Lipton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betzaida","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-6144","authenticated-orcid":false,"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Sheikhi","family":"Mehrabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-2846","authenticated-orcid":false,"given":"Fred","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-0514","authenticated-orcid":false,"given":"Robert E.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-2095","authenticated-orcid":false,"given":"Margaret","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-6640","authenticated-orcid":false,"given":"Sait","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2725-9739","authenticated-orcid":false,"given":"Robert A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7929-3704","authenticated-orcid":false,"given":"E. Jolanda","family":"Muenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"10440","key":"3428_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"key":"3428_CR2","unstructured":"Evaluation IfHMa. Migraine YLDs (Years Lived with Disability): University of Washington; 2021 https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"issue":"1","key":"3428_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, et al. Hallmarks of primary headache: part 1\u2014migraine. J Headache Pain. 2024;25(1):189.","journal-title":"J Headache Pain"},{"issue":"4","key":"3428_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/head.14103","volume":"61","author":"DC Buse","year":"2021","unstructured":"Buse DC, Armand CE, Charleston Lt, Reed ML, Fanning KM, Adams AM, et al. Barriers to care in episodic and chronic migraine: results from the chronic migraine epidemiology and outcomes study. Headache. 2021;61(4):628\u201341.","journal-title":"Headache"},{"issue":"5","key":"3428_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, et al. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2016;56(5):821\u201334.","journal-title":"Headache"},{"issue":"1","key":"3428_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02265.x","volume":"53","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache. 2013;53(1):81\u201392.","journal-title":"Headache"},{"issue":"8","key":"3428_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/head.14729","volume":"64","author":"S Ashina","year":"2024","unstructured":"Ashina S, Muenzel EJ, Nicholson RA, Zagar AJ, Buse DC, Reed ML, et al. Machine learning identifies factors most associated with seeking medical care for migraine: results of the OVERCOME (US) study. Headache. 2024;64(8):1027\u201339.","journal-title":"Headache"},{"issue":"3","key":"3428_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"A Blumenfeld","year":"2011","unstructured":"Blumenfeld A, Varon S, Wilcox T, Buse D, Kawata A, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301\u201315.","journal-title":"Cephalalgia"},{"issue":"6","key":"3428_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/14656566.2024.2349791","volume":"25","author":"L Pellesi","year":"2024","unstructured":"Pellesi L, Do TP, Hougaard A. Pharmacological management of migraine: current strategies and future directions. Expert Opin Pharmacother. 2024;25(6):673\u201383.","journal-title":"Expert Opin Pharmacother"},{"issue":"15_supplement","key":"3428_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.96.15_supplement.1514","volume":"96","author":"SJ Nahas","year":"2021","unstructured":"Nahas SJ, Buse DC, Hutchinson S, Reed ML, Fanning KM, Dabruzzo B, et al. Characterizing preventive treatment gaps in migraine: results from the CaMEO study (1514). Neurology. 2021;96(15_supplement):1514.","journal-title":"Neurology"},{"issue":"2","key":"3428_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1526-4610.2011.02032.x","volume":"52","author":"MK Chu","year":"2012","unstructured":"Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(2):213\u201323.","journal-title":"Headache"},{"issue":"10077","key":"3428_CR12","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0140-6736(17)30398-7","volume":"389","author":"SL Dickman","year":"2017","unstructured":"Dickman SL, Himmelstein DU, Woolhandler S. Inequality and the health-care system in the USA. Lancet. 2017;389(10077):1431\u201341.","journal-title":"Lancet"},{"key":"3428_CR13","doi-asserted-by":"crossref","unstructured":"Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. Jama. 1992;267(1):64\u20139.","DOI":"10.1001\/jama.1992.03480010072027"},{"issue":"11","key":"3428_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1212\/WNL.0b013e3182a43b32","volume":"81","author":"WF Stewart","year":"2013","unstructured":"Stewart WF, Roy J, Lipton RB. Migraine prevalence, socioeconomic status, and social causation. Neurology. 2013;81(11):948\u201355.","journal-title":"Neurology"},{"issue":"2","key":"3428_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, et al. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache. 2022;62(2):122\u201340.","journal-title":"Headache"},{"issue":"3","key":"3428_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208074","volume":"102","author":"RE Shapiro","year":"2024","unstructured":"Shapiro RE, Nicholson RA, Seng EK, Buse DC, Reed ML, Zagar AJ, et al. Migraine-related stigma and its relationship to disability, interictal burden, and quality of life: results of the OVERCOME (US) study. Neurology. 2024;102(3):e208074.","journal-title":"Neurology"},{"issue":"1","key":"3428_CR17","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"8","key":"3428_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157\u201368.","journal-title":"Headache"},{"issue":"7","key":"3428_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS, Society tBoDotAH. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021\u201339.","journal-title":"Headache"},{"key":"3428_CR20","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20f13681","author":"C Andrade","year":"2020","unstructured":"Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020. https:\/\/doi.org\/10.4088\/JCP.20f13681.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"3428_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"issue":"4","key":"3428_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/head.13286","volume":"58","author":"Lt Charleston","year":"2018","unstructured":"Charleston Lt, Royce J, Monteith TS, Broner SW, O\u2019Brien HL, Manrriquez SL, et al. Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 1. Headache. 2018;58(4):506\u201311.","journal-title":"Headache"},{"issue":"5","key":"3428_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/head.13321","volume":"58","author":"Lt Charleston","year":"2018","unstructured":"Charleston Lt, Royce J, Monteith TS, Broner SW, O\u2019Brien HL, Manrriquez SL, et al. Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 2. Headache. 2018;58(5):633\u201347.","journal-title":"Headache"},{"issue":"1","key":"3428_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/head.14659","volume":"64","author":"C Rhudy","year":"2024","unstructured":"Rhudy C, Schadler A, Huffmyer M, Porter L. Rural disparities in emergency department utilization for migraine care. Headache. 2024;64(1):37\u201347.","journal-title":"Headache"},{"issue":"6","key":"3428_CR25","first-page":"671","volume":"113","author":"F Amico","year":"2022","unstructured":"Amico F, Ashina S, Parascandolo E, Sharon R. Race, ethnicity, and other sociodemographic characteristics of patients with hospital admission for migraine in the United States. J Natl Med Assoc. 2022;113(6):671\u20139.","journal-title":"J Natl Med Assoc"},{"key":"3428_CR26","unstructured":"Ailani J MJ, Johnston E , Hochstetler H , Martinez B ,Okonkwo R , Nicholson R , Vargas B , Lipton R, editor Patient reluctance as a possible barrier to takingmigraine preventive medications: Results of the OVERCOME (US)study. American Headache Society 66th Annual Scientific Meeting; 2024; San Diego, California. Headache2024."},{"issue":"5","key":"3428_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/head.14709","volume":"64","author":"F Cohen","year":"2024","unstructured":"Cohen F, Brooks CV, Sun D, Buse DC, Reed ML, Fanning KM, et al. Prevalence and burden of migraine in the United States: a systematic review. Headache. 2024;64(5):516\u201332.","journal-title":"Headache"},{"issue":"8","key":"3428_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/head.13613","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, et al. Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2019;59(8):1286\u201399.","journal-title":"Headache"},{"issue":"1","key":"3428_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/JOM.0b013e3181c1dc56","volume":"52","author":"WF Stewart","year":"2010","unstructured":"Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52(1):8\u201314.","journal-title":"J Occup Environ Med"},{"issue":"1","key":"3428_CR30","doi-asserted-by":"publisher","first-page":"21988","DOI":"10.1038\/s41598-023-49088-z","volume":"13","author":"H Majeed","year":"2023","unstructured":"Majeed H, Baumann S, Majeed H. Understanding the association between county-level unemployment and health stratified by education and income in the southwestern United States. Sci Rep. 2023;13(1):21988.","journal-title":"Sci Rep"},{"key":"3428_CR31","doi-asserted-by":"crossref","unstructured":"Schudde L, Bernell K. Educational Attainment and Nonwage Labor Market Returns in the United States. AERA Open. 2019;5(3).","DOI":"10.1177\/2332858419874056"},{"issue":"5","key":"3428_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0025-6196(11)60561-2","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422\u201335.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"3428_CR33","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1526-4610.2001.01156.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41(9):854\u201361.","journal-title":"Headache"},{"issue":"6, Suppl1","key":"3428_CR34","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6, Suppl1):S20\u20138.","journal-title":"Neurology"},{"issue":"4","key":"3428_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1526-4610.1998.3804295.x","volume":"38","author":"P Jhingran","year":"1998","unstructured":"Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the migraine-specific quality of life questionnaire. Headache. 1998;38(4):295\u2013302.","journal-title":"Headache"},{"issue":"5","key":"3428_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/head.13497","volume":"59","author":"RM Speck","year":"2019","unstructured":"Speck RM, Shalhoub H, Wyrwich KW, Yu R, Ayer DW, Ford J, et al. Psychometric validation of the role function restrictive domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in patients with episodic and chronic migraine. Headache. 2019;59(5):756\u201374.","journal-title":"Headache"},{"issue":"1\u20132","key":"3428_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B L\u00f6we","year":"2010","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1\u20132):86\u201395.","journal-title":"J Affect Disord"},{"key":"3428_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/head.14886","author":"EK Seng","year":"2025","unstructured":"Seng EK, Muenzel EJ, Shapiro RE, Buse DC, Reed ML, Zagar AJ, et al. Development of the migraine-related stigma (MiRS) questionnaire: results of the OVERCOME (US) study. Headache. 2025. https:\/\/doi.org\/10.1111\/head.14886.","journal-title":"Headache"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03428-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03428-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03428-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:30:37Z","timestamp":1773822637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03428-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3428"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03428-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Richard B. Lipton has received research support from the National Institutes of Health, the FDA, and the National Headache Foundation. He serves as consultant, advisory board member, or has received honoraria or research support from AbbVie\/Allergan, Amgen, Axsome, Biohaven, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer, Teva, Vector, and Vedanta Research. He receives royalties from Wolff's Headache, 8th edition (Oxford University Press, 2009), and Informa. He holds stock\/options in Biohaven, Cooltech, Mainistee, and NuVieBio. Betzaida Martinez is an employee and minor stockholder of Eli Lilly and Company. Dawn C. Buse has received research support from the United States Food and Drug Administration (FDA) and the National Headache Foundation. She serves as consultant, advisory board member, or has received honoraria or research support from AbbVie\/Allergan, Amgen, Biohaven, Eli Lilly and Company, Lundbeck, Novartis, Teva and Theranica. Ali Sheikhi Mehrabadi is an employee and minor stockholder of Eli Lilly and Company. Anthony J. Zagar is an employee and minor stockholder of Eli Lilly and Company. Fred Cohen\u00a0has received honoraria from Abbvie (consulting, speaking), Eli Lilly (speaking), and Pfzier (consulting, speaking). He serves as an assistant editor for\u00a0Headache. He has received honoraria for Medlink Neurology and Springer Nature. Robert E. Shapiro serves as consultant, advisory board member, or has received honoraria or research support from Eli Lilly and Company, AbbVie, Theranica, Amneal, and Lundbeck. Margaret Hoyt is an employee and minor stockholder of Eli Lilly and Company. Sait Ashina consulting, teaching, honoraria: Allergan\/Abbvie, Amgen, Biohaven Pharmaceuticals, Eli Lilly and Company, Impel NeuroPharma, Linpharma, Lundbeck, Novartis, Satsuma, Supernus, Percept, Pfizer, Teva and Theranica. Robert A. Nicholson is an employee and minor stockholder of Eli Lilly and Company. Eva Jolanda Muenzel is an employee and minor stockholder of Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Sterling Institutional Review Board (IRB ID #6425\u2013001). Random panel participants were emailed invitations to participate in an online general health survey. Interested respondents voluntarily provided electronic informed consent and received honoraria in the form of survey panel points. Permission to use the Migraine Interictal Burden Scale-4 (MIBS-4) was obtained for the study. This study\u00a0was\u00a0performed in accordance with\u00a0the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}